Technology
Vessel-Wave – SUCCESS PAGE – June 18, 2026
Vessel Wave Technologies is addressing a large and growing cardiovascular issue with the first aortic stent-graft designed to mimic the natural elasticity of the aorta
Vessel Wave Technologies is addressing a large and growing cardiovascular issue with the first aortic stent-graft designed to mimic the natural elasticity of the aorta
The first company to deliver the true cold coffee experience to homes, hotels, restaurants, and every other place where people enjoy coffee
Myris Therapeutics is revolutionizing the delivery of small molecule cancer therapies with its HiDAR Precision Medicine Platform
Ticonderoga Strategic Event Fund focuses event-driven opportunities and mispriced situations created by today’s improving M&A landscape
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
Vessel Wave Technologies is addressing a large and growing cardiovascular issue with the first aortic stent-graft designed to mimic the natural elasticity of the aorta
The first company to deliver the true cold coffee experience to homes, hotels, restaurants, and every other place where people enjoy coffee
Myris Therapeutics is revolutionizing the delivery of small molecule cancer therapies with its HiDAR Precision Medicine Platform
Ticonderoga Strategic Event Fund focuses event-driven opportunities and mispriced situations created by today’s improving M&A landscape
troCarWash has the potential to shorten operation times, improve outcomes, and reduce costs
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Oban BioPharma is developing a novel oral treatment class for Type 2 diabetes and obesity that works across multiple pathways involved in metabolism at once